Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Black Diamond Therapeutics, Inc. - Common Stock (NQ:BDTX)

2.625 -0.025 (-0.94%)
Streaming Delayed Price Updated: 1:02 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Black Diamond Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
What 6 Analyst Ratings Have To Say About Black Diamond Therapeutic ↗
 
Via Benzinga
News headline image
Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Where Black Diamond Therapeutic Stands With Analysts ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Black Diamond Therapeutic ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 ↗
 
Via Benzinga
News headline image
$4.7M Bet On Black Diamond Therapeutics? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the... 
Via Benzinga
News headline image
$1M Bet On Children's Place? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
$5M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed slightly higher on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
Genuine Monotherapy Approach In EGFRm NSCLC: Analyst Upgrades Switches To Buy On Black Diamond Therapeutics ↗
Tuesday, Black Diamond Therapeutics Inc (NASDAQ: BDTX) announced initial clinical data from the dose escalation portion of Phase 1 clinical study of BDTX-1535 for non-small cell lung cancer (NSCLC)  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗
 
Via Benzinga
News headline image
$1.5M Bet On ONEOK? Check Out These 3 Stocks Insiders Are Buying ↗
Although US stocks closed mostly higher on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today! 
Via InvestorPlace
News headline image
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
Why Shares of Black Diamond Therapeutics Skyrocketed This Week ↗
The company announced positive early-trial news for non-small cell lung cancer. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket ↗
Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today! 
Via InvestorPlace
News headline image
Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023 ↗
 
Via Benzinga
News headline image
Tesla And Nvidia Lead The Charge As Stocks Surge: Top Trends Of The Day ↗
 
Via Benzinga
News headline image
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42.... 
Via Benzinga
News headline image
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Black Diamond Therapeutics’ (NASDAQ: BDTX) BDTX-1535 Proves Promising for EGFR Mutated NSCLC and GBM
Black Diamond Therapeutics has announced encouraging initial data from a Phase 1 study of BDTX-1535, an investigational fourth-generation EGFR MasterKey 
Via Spotlight Growth
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.